Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00018564 |
This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.
Condition | Intervention | Phase |
---|---|---|
Essential Tremor |
Drug: treatments for essential tremor |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study |
Official Title: | Novel Therapies for Essential Tremor |
Study Start Date: | October 2000 |
Estimated Study Completion Date: | September 2003 |
Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Study ID Numbers: | NEUD-048-00S |
Study First Received: | July 3, 2001 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00018564 |
Health Authority: | United States: Federal Government |
Signs and Symptoms Essential Tremor Movement Disorders Benign essential tremor syndrome |
Central Nervous System Diseases Neurologic Manifestations Dyskinesias Tremor |
Nervous System Diseases |